Why consider treatment in China for ALS / Motor Neuron Disease?

China offers the world's largest clinical cohort for intrathecal umbilical cord mesenchymal stem cell (UC-MSC) therapy combined with intensive rehabilitation for ALS. This experimental treatment is available at a fraction of the cost of similar therapies in Western countries, with experienced medical teams who have treated hundreds of international patients. While not a cure, it aims to slow disease progression and improve quality of life.